Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2026-03-27 @ 8:43 AM
Study NCT ID:
NCT01581203
Status:
COMPLETED
Last Update Posted:
2015-10-09
First Post:
2012-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatitis C Virus | View |
Keywords: